Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
508
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Characteristics and risk factors of infections following CD28-based CD19 CAR-T cells

Talya Wittmann Dayagia Department of Pediatrics, The Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;b Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Gilad Shermana Department of Pediatrics, The Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;b Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Bella Bieloraib Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;c Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
,
Etai Adamc Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
,
Michal J. Besserb Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;d Ella Institute of Immuno-Oncology, Sheba Medical Center, Ramat Gan, Israel
,
Avichai Shimonib Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;e Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel
,
Arnon Naglerb Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;e Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel
,
Amos Torenb Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;c Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
,
Elad Jacobyb Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;c Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1411-8942
ORCID Icon &
Abraham Avigdorb Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;e Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel
 show all
Pages 1692-1701 | Received 19 Sep 2020, Accepted 17 Jan 2021, Published online: 10 Feb 2021

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gülçin Telli Dizman, José María Aguado & Mario Fernández-Ruiz. (2022) Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis. Expert Review of Anti-infective Therapy 20:11, pages 1455-1476.
Read now

Articles from other publishers (11)

Arnon Nagler, Vincenzo Maria Perriello, Lorenza Falini & Brunangelo Falini. (2023) How I treat refractory/relapsed diffuse large B‐cell lymphomas with CD19 ‐directed chimeric antigen receptor T cells . British Journal of Haematology 201:3, pages 396-410.
Crossref
Danya Shen, Biqi Zhou, Meng Shan, Xuekai Li, Mengqian Chu, Yifan Shen, Yuchen Zhan, Jie Xu, Depei Wu & Yang Xu. (2023) Evaluation of the Diagnostic Performance of Plasma Metagenomic Next-Generation Sequencing in Febrile Events in the First 30 Days after Chimeric Antigen Receptor T Cell Infusion. Transplantation and Cellular Therapy 29:5, pages 304.e1-304.e8.
Crossref
Benoît Pilmis, Yousra Kherabi, Pauline Huriez, Jean-Ralph Zahar & Djamel Mokart. (2023) Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas. Cancers 15:7, pages 1989.
Crossref
Bryanna Reinhardt, Patrick Lee & Joshua P. Sasine. (2023) Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis. Cells 12:4, pages 531.
Crossref
Juan C. Gea-Banacloche. (2023) Infectious complications of chimeric antigen receptor (CAR) T-cell therapies. Seminars in Hematology 60:1, pages 52-58.
Crossref
Ester Márquez-Algaba, Gloria Iacoboni, Berta Pernas, Juliana Esperalba, Ibai Los Arcos, Victor Navarro, Arnau Monforte, Francisco Beas, Adaia Albasanz-Puig, Cecilia Carpio, Pere Barba & Isabel Ruiz-Camps. (2022) Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy 28:12, pages 851.e1-851.e8.
Crossref
George Chen, Megan Herr, Jan Nowak, Christine Ho, Nikolaos Almyroudis, Kristopher Attwood, John Bonnewell, Marissa Walsh, Brahm Segal, Maureen Ross, Philip McCarthy & Theresa Hahn. (2022) Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant. Haematologica 108:2, pages 615-620.
Crossref
Kitsada Wudhikarn & Miguel-Angel Perales. (2022) Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy. Bone Marrow Transplantation 57:10, pages 1477-1488.
Crossref
Sandrine Valade, Michael Darmon, Lara Zafrani, Eric Mariotte, Virginie Lemiale, Swann Bredin, Guillaume Dumas, Nicolas Boissel, Florence Rabian, André Baruchel, Isabelle Madelaine, Jérôme Larghero, Anne Brignier, Etienne Lengliné, Stéphanie Harel, Bertrand Arnulf, Roberta Di Blasi, Catherine Thieblemont & Elie Azoulay. (2022) The use of ICU resources in CAR-T cell recipients: a hospital-wide study. Annals of Intensive Care 12:1.
Crossref
Daniel K. Yeoh, Gabrielle M. Haeusler, Brendan J. McMullan, Coen Butters, Penelope A. Bryant, Julia E. Clark, Celia M. Cooper, Amanda Gwee, Rishi S. Kotecha, Tony Lai, Monica A. Slavin, Karin A. Thursky & Christopher C. Blyth. (2022) Antifungal use in children with acute leukaemia: state of current evidence and directions for future research. Journal of Antimicrobial Chemotherapy 77:6, pages 1508-1524.
Crossref
Adam G. Stewart & Andrea S. Henden. (2021) Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease 8, pages 204993612110367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.